Module 4: Pharmacotherapy for Alcohol Use Disorder

Describes and compares pharmacological treatment options for individuals with AUD, including FDA- approved medications acamprosate, disufiram, and naltrexone, as well as two other evidence-based treatments that are not yet FDA approved, topiramate and gabapentin; includes diagnosis of AUD, definitions of binge drinking and “at risk” drinking, and a case vignette; up to 1 AMA PRA Category 1 Credit™ for continuing education